Literature DB >> 16822360

Revascularization for patients with severe coronary artery disease and left ventricular dysfunction.

Tapas Ghose1, Randall C Thompson.   

Abstract

Heart failure is becoming increasingly prevalent, and currently coronary artery disease (CAD) is the primary cause of left ventricular (LV) systolic dysfunction. A potential therapeutic option for patients with severe CAD and LV dysfunction is a strategy of revascularization. In this review, we summarize the available literature regarding revascularization for these patients. The literature suggests that patients with severe CAD and LV dysfunction may benefit from revascularization and those patients with viable myocardium may derive the most benefit.

Entities:  

Mesh:

Year:  2006        PMID: 16822360     DOI: 10.1007/s11886-006-0055-5

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  18 in total

1.  Revascularization in severe ventricular dysfunction (15% < OR = LVEF < OR = 30%): a comparison of bypass grafting and percutaneous intervention.

Authors:  Koichi Toda; Karen Mackenzie; Mandeep R Mehra; Charles J DiCorte; James E Davis; P Michael McFadden; John L Ochsner; Christopher White; Clifford H Van Meter
Journal:  Ann Thorac Surg       Date:  2002-12       Impact factor: 4.330

2.  Extensive left ventricular remodeling does not allow viable myocardium to improve in left ventricular ejection fraction after revascularization and is associated with worse long-term prognosis.

Authors:  Jeroen J Bax; Arend F L Schinkel; Eric Boersma; Abdou Elhendy; Vittoria Rizzello; Alexander Maat; Jos R T C Roelandt; Ernst E van der Wall; Don Poldermans
Journal:  Circulation       Date:  2004-09-14       Impact factor: 29.690

Review 3.  Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention and medical therapy for multivessel disease with and without left ventricular dysfunction.

Authors:  Amitra E B Caines; Malek G Massad; Jacques Kpodonu; Abdallah G Rebeiz; Alexander Evans; Alexander S Geha
Journal:  Cardiology       Date:  2004       Impact factor: 1.869

4.  A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fraction.

Authors:  E Passamani; K B Davis; M J Gillespie; T Killip
Journal:  N Engl J Med       Date:  1985-06-27       Impact factor: 91.245

5.  Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina.

Authors: 
Journal:  N Engl J Med       Date:  1984-11-22       Impact factor: 91.245

6.  Stent supported coronary angioplasty in patients with severe ventricular dysfunction.

Authors:  Chengxiang Li; Guoliang Jia; Wenyi Guo; Weijie Li
Journal:  Chin Med J (Engl)       Date:  2002-03       Impact factor: 2.628

Review 7.  What is the evidence for percutaneous coronary intervention or coronary artery bypass graft in ischemic cardiomyopathy?

Authors:  Douglass A Morrison
Journal:  Am Heart Hosp J       Date:  2005

8.  Myocardial infarction and mortality in the coronary artery surgery study (CASS) randomized trial.

Authors: 
Journal:  N Engl J Med       Date:  1984-03-22       Impact factor: 91.245

9.  Comparison of coronary artery bypass surgery and medical therapy in patients 65 years of age or older. A nonrandomized study from the Coronary Artery Surgery Study (CASS) registry.

Authors:  B J Gersh; R A Kronmal; H V Schaff; R L Frye; T J Ryan; M B Mock; W O Myers; M W Athearn; A J Gosselin; G C Kaiser
Journal:  N Engl J Med       Date:  1985-07-25       Impact factor: 91.245

Review 10.  The heart failure revascularisation trial (HEART): rationale, design and methodology.

Authors:  J G F Cleland; N Freemantle; S G Ball; R S Bonser; P Camici; S Chattopadhyay; D Dutka; J Eastaugh; J Hampton; S Large; M S Norell; D J Pennell; J Pepper; S Sanda; R Senior; D Smith
Journal:  Eur J Heart Fail       Date:  2003-06       Impact factor: 15.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.